IP Library › Granted Patent US 8,039,467
Granted Patent B2
US 8,039,467 · App. 12/582,341 · Granted Oct 18, 2011

Compounds for the treatment of inflammatory disorders

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,039,467
App. No.
12/582,341
Granted
Oct 18, 2011
Kind
B2
Abstract

This invention relates to compounds of the Formula (I): or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, TNF-α or combinations thereof.

Claims (6)

1. A compound selected from the group consisting of:

or a pharmaceutically acceptable salt thereof.

2. The compound of claim 1 or a pharmaceutically acceptable salt thereof, wherein the compound is

3. The compound of claim 1 or a pharmaceutically acceptable salt thereof, wherein the compound is

4. The compound of claim 1 or a pharmaceutically acceptable salt thereof, wherein the compound is

5. A pharmaceutical composition comprising the compound of claim 1 or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable carrier.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →